Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GSK to acquire U.S.-based BELLUS Health for $14.75 per share By: MarketWatch April 18, 2023 at 02:33 AM EDT GSK said the deal will provide access to camlipixant, a treatment for refractory chronic cough currently in phase III development. Read More >> Related Stocks: Bellus Health Inc Gsk Plc ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
GSK to acquire U.S.-based BELLUS Health for $14.75 per share By: MarketWatch April 18, 2023 at 02:33 AM EDT GSK said the deal will provide access to camlipixant, a treatment for refractory chronic cough currently in phase III development. Read More >> Related Stocks: Bellus Health Inc Gsk Plc ADR
